Kiniksa Pharmaceuticals, Ltd.
Utility Patent Applications

Last updated:

List of all Kiniksa Pharmaceuticals, Ltd. patents 9 in total

Status Patent
Application
Utility: PROTEIN COMPOSITIONS AND METHODS FOR PRODUCING AND USING THE SAME External link
Filling date: 9 Sep 2025 Issue date: 8 Sep 2022
Application
Utility: TREATMENT OF CANCERS WITH GM-CSF ANTAGONISTS External link
Filling date: 9 Sep 2025 Issue date: 16 Jun 2022
Application
Utility: Stable Anti-OSMR Antibody Formulation External link
Filling date: 9 Sep 2025 Issue date: 3 Mar 2022
Application
Utility: ONCOSTATIN M RECEPTOR ANTIGEN BINDING PROTEINS External link
Filling date: 9 Sep 2025 Issue date: 24 Feb 2022
Application
Utility: TREATMENT OF CYTOKINE RELEASE SYNDROME WITH GM-CSF ANTAGONISTS External link
Filling date: 9 Sep 2025 Issue date: 16 Sep 2021
Application
Utility: TREATMENT OF CYTOKINE RELEASE SYNDROME WITH GM-CSF ANTAGONISTS External link
Filling date: 9 Sep 2025 Issue date: 16 Sep 2021
Application
Utility: TREATMENT OF SKIN DISEASES OR DISORDERS BY DELIVERY OF ANTI-OSMRB ANTIBODY External link
Filling date: 9 Sep 2025 Issue date: 25 Feb 2021
Application
Utility: Stable Anti-OSMR Antibody Formulation External link
Filling date: 9 Sep 2025 Issue date: 27 Feb 2020
Application
Utility: ONCOSTATIN M RECEPTOR ANTIGEN BINDING PROTEINS External link
Filling date: 9 Sep 2025 Issue date: 28 Nov 2019

Showing 1 to 9 of 9 patents.